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J.S. Lindholt
Elitary Research Centre of Individualised Medicine of Arterial Disease (CIMA), Department of Cardiothoracic and Vascular Surgery, Odense University Hospital,
DenmarkIn this edition of EJVES, the Gloucester group report that 18% fundamental criteria for screening formulated by the WHO.
of screen diagnosed cases of abdominal aortic aneurysms
(AAAs) in need of preventive repair haven’t received repair
after 3 months; 22% of these received repair later on with no
30 day post-operative deaths, so the ﬁnal turn down rate was
13%.1 The reasons are not given, but could be a sign of a kind
of “intelligent waiting” where you take the chance of repair if
progression is worrying, weak symptoms develop, or health
conditions improve.
However, “intelligent waiting” is a dangerous strategy
because about 20% of patients in the current report experi-
enced rupture. Clearly, earlier intervention seems more
attractive. In addition, three major questions arise from this
report if generalisation is possible.
When we created a model to evaluate cost-effectiveness of
screening for AAA in a modern context, we needed to know
the proportion not repaired, and studied the four AAA
screening randomised controlled trials; 15% didn’t receive
repair.2,3 However, these ﬁgures are mainly from the 1990s
when the operative risk was 5% before endovascular aneu-
rysm repair and the knowledge that treatment of screen
detected cases carries a one third risk compared with inci-
dentally detected cases.4 However, initial results from the
British National AAA screening programme (BNASP) reported
that 26% of 417 referred patients weren’t yet repaired, and
although probably biased by other factors, the proportion
seems very high.5
The ﬁrst major question to be raised is whether screening is
still beneﬁcial and cost-effective. As mentioned, such rejection
fractions for repair were also seen in the MASS and Viborg trials,
both of which have reported efﬁcient and cost-effective
screening programmes. In order to evaluate the consequences
in a modern context,2 we ran sensitivity analyses of our modern
model in which the originally used unﬁt proportion was
exchanged with the proportions reported from Gloucester and
the BNASP, respectively. It showed decreased efﬁcacy from 32%
to 30% and 23% reduced AAA speciﬁc mortality, respectively.
Whether it remains cost-effective needs further time consuming
calculations to clarify.
A second major question to be raised is whether one of ﬁve
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http://dx.doi.org/10.1016/j.ejvs.2015.08.017Although some of them receive repair later, the initial refusal
leaves the patients with the knowledge of having a life
threatening condition with the obvious risk of losing life and
quality of life. However, it seems to be correctable as the
potentially maintained high rejection rate is combined with a
tremendous decline in the operative risk from about 5% to
about 1%.4
We must not forget when the size criterion of 55 mm is met
the condition is life threatening. If we assume the median size
of referred AAAs is 6 cm and such an AAA carries an annual
rupture risk of 10% with 75% overall mortality,2,6 then survival
curves of early surgery populations will cross those deemed
unﬁt after just 1 year if the operative risk is as high as 7.5%.
Modern public surveillance of results and risk of audits may
have triggered this development, especially in Great Britain
where individual surgeon outcomes are published.7
Consequently, the third major question is whether we as
vascular surgeons have failed by continuing to select people to
repair using outdated criteria that are no longer balanced by
the decreased risk of repair?
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